The methotrexate polyglutamate assay supports the efficacy of methotrexate for severe inflammatory skin disease in children
- 1 February 2014
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 70 (2) , 252-256
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Low-Dose Methotrexate Results in the Selective Accumulation of Aminoimidazole Carboxamide Ribotide in an Erythroblastoid Cell LineThe Journal of Pharmacology and Experimental Therapeutics, 2013
- A comparative study of childhood psoriasis and atopic dermatitis and greater understanding of the overlapping condition, psoriasis‐dermatitisAustralasian Journal of Dermatology, 2012
- Methotrexate polyglutamates as a marker of patient compliance and clinical response in psoriasis: a single-centre prospective studyBritish Journal of Dermatology, 2012
- The use of methotrexate in dermatology: a reviewAustralasian Journal of Dermatology, 2011
- Polymorphisms in Folate, Pyrimidine, and Purine Metabolism Are Associated with Efficacy and Toxicity of Methotrexate in PsoriasisJournal of Investigative Dermatology, 2007
- Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritisArthritis & Rheumatism, 2006
- PsEma—A Hitherto Unnamed Dermatologic Entity With Clinical Features of Both Psoriasis and EczemaSKINmed: Dermatology for the Clinician, 2005
- Toward a better understanding of methotrexateArthritis & Rheumatism, 2004
- HPLC Determination of Erythrocyte Methotrexate Polyglutamates after Low-Dose Methotrexate Therapy in Patients with Rheumatoid ArthritisClinical Chemistry, 2003